A top medical journal has cast doubt on whether a testosterone patch designed to boost post-menopausal women's flagging sex drive actually works.
The patch is designed for post-menopausal women
The Drug and Therapeutics Bulletin (DTB) also said the long-term safety of Intrinsa remained unproven.
It criticised trials of the treatment as flawed and inconclusive.
The makers, Procter & Gamble Pharmaceuticals, said Intrinsa had been thoroughly tested, and had been shown to be effective.
 |  We cannot recommend Intrinsa for use in women with sexual dysfunction  Drug and Therapeutics Bulletin |
There is some evidence that the condition may be linked to low levels of the sex hormone testosterone.
Intrinsa is designed to address the problem by releasing a daily dose of the hormone into the blood stream from a patch worn on the lower abdomen.
It is prescribed for women with HSDD who are also receiving therapy to top up levels of another sex hormone, oestrogen.
The patch was licensed by the European Medicines Evaluation Read more...
{ 0 comments... Views All / Send Comment! }
Post a Comment